Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSIST-CLAD
NCT02709343Phase 2Completed
- Sponsor
- The University of Queensland
- Start
- Apr 2017
- Primary completion
- Sep 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human bone marrow mesenchymal stem cell in chronic lung allograft dysfunction (CLAD), sponsored by The University of Queensland. Started Apr 2017; status: completed.
02
Drugs
human bone marrow mesenchymal stem cell
03
Conditions
chronic lung allograft dysfunction (CLAD)
Beyond the preview
Go deeper on NCT02709343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02709343.